S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma
NCT03668366
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
133
Enrollment
OTHER
Sponsor class
Conditions
Nasopharyngeal Carcinoma
Interventions
DRUG:
S-1
Sponsor
Fudan University